Mednet Logo
HomeInfectious DiseaseQuestion

How do you approach biologic initiation in patients with inflammatory arthritis and repeatedly indeterminate Quantiferon?

4
5 Answers
Mednet Member
Mednet Member
Infectious Disease · Cornell Medical School

This is an unusual but anxiety-inducing situation.

Remember that an "indeterminate" Quantiferon is not an "intermediate" Quantiferon. It's not half-positive, it's uninterpretable. The result provides absolutely no reason to be more or less concerned that the patient has lTB, latent or otherwise.

I a...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Rheumatology · Mobile Medical Care Inc

Indeterminate Quantiferon Gold testing can result from corticosteroid exposure in the time preceding the blood draw. There is good reason to check the steroid exposure history and ensure a steroid-free period of at least a month before making a decision about tuberculosis exposure. Alternatively, a ...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Rheumatology · Icahn School of Medicine at Mount Sinai

The T-spot test, similar to the in tube quantiferon assays, are all interferon-g release assays. They are able to utilize specific antigens such as ESAT-6 and CF-10 that are not represented in BCG, giving it that advantage in terms of specificity. But immunosuppressants such as glucocorticoids or an...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Rheumatology · Gulf Coast Rheumatology

Also, don't forget if the patient is on HCQ that can affect the assay and hence results as another confounder.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Infectious Disease · Saint Francis Hospital

Generally tend to treat, depending on

  • specific immunosuppressive regimen,
  • epidemiological likelihood of TB exposure, and
  • tolerance of TB regimen (more likely to treat if regimen clinically and chemically well tolerated).

Register or Sign In to see full answer